
Precision Optics Corporation, Inc.
Precision Optics Corporation, Inc. (POCI) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
poci · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Precision Optics Corporation, Inc.You POCI | $43M | N/A | — | — |
Apimeds Pharmaceuticals US, Inc APUS | $1M | N/A | — | -$0.55 |
Harvard Bioscience, Inc. HBIO | $26M | N/A | — | -$12.77 |
IGC Pharma, Inc. IGC | $29M | N/A | — | -$0.07 |
MIRA Pharmaceuticals, Inc. MIRA | $42M | N/A | — | -$0.44 |
Milestone Scientific Inc. MLSS | $34M | N/A | — | -$0.07 |
Modular Medical, Inc. MODD | $10M | N/A | — | -$15.26 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Precision Optics Corporation, Inc. (POCI) measures how much investors pay for each dollar of the company's trailing earnings. POCI's current PE ratio of N/A is calculated by dividing its stock price of $5.62 by its TTM earnings per share of —.
Frequently asked questions
POCI pe ratio · 6 questionsPOCI's current PE ratio is N/A as of 2026-06-09, based on a stock price of $5.62 and TTM EPS of —. Data sourced from Financial Modeling Prep via POCI's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Precision Optics Corporation, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09